Related Articles
BRCA1 mutation in breast cancer patients: Analysis of prognostic factors and survival
Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide
Molecular characteristics of breast cancer according to clinicopathological factors
Characterization of mutations in BRCA1/2 and the relationship with clinic‑pathological features of breast cancer in a hereditarily high‑risk sample of chinese population
Triple‑negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia